Riego Joseph A, Broniowska Katarzyna A, Kettenhofen Nicholas J, Hogg Neil
Department of Biophysics and Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Free Radic Biol Med. 2009 Aug 1;47(3):269-74. doi: 10.1016/j.freeradbiomed.2009.04.027. Epub 2009 May 3.
In this study the mechanism by which S-nitrosocysteine (CysNO) activates soluble guanylyl cyclase (sGC) has been investigated. CysNO is the S-nitrosated derivative of the amino acid cysteine and has previously been shown to be transported into various cell types by amino acid transport system L. Here we show, using both neuroblastoma and pulmonary artery smooth muscle cells, that CysNO stimulates cGMP formation at low concentrations, but this effect is lost at higher concentrations. Stimulation of cGMP accumulation occurs only after its transport into the cell and subsequent flavoprotein reductase-mediated metabolism to form nitric oxide (NO). Consequently, CysNO can be regarded as a cell-targeted NO-releasing agent. However, CysNO also functions as an NO-independent thiol-modifying agent and can compromise cellular antioxidant defenses in a concentration-dependent manner. The observed biphasic nature of CysNO-dependent cGMP accumulation seems to be due to these two competing mechanisms. At higher concentrations, CysNO probably inactivates guanylyl cyclase through modification of an essential thiol group on the enzyme, either directly or as a result of a more generalized oxidative stress. We show here that higher concentrations of CysNO can increase cellular S-nitrosothiol content to nonphysiological levels, deplete cellular glutathione, and inhibit cGMP formation in parallel. Although the inhibition of sGC by S-nitrosation has been suggested as a mechanism of nitrovasodilator tolerance, in the case of CysNO, it seems to be more a reflection of a generalized oxidative stress placed upon the cell by the nonphysiological levels of intracellular S-nitrosothiol generated upon CysNO exposure.
在本研究中,对S-亚硝基半胱氨酸(CysNO)激活可溶性鸟苷酸环化酶(sGC)的机制进行了研究。CysNO是氨基酸半胱氨酸的S-亚硝基化衍生物,先前已证明它可通过氨基酸转运系统L转运到各种细胞类型中。在此我们使用神经母细胞瘤细胞和肺动脉平滑肌细胞均表明,CysNO在低浓度时刺激cGMP生成,但在较高浓度时这种作用消失。cGMP积累的刺激仅在其转运进入细胞并随后由黄素蛋白还原酶介导代谢形成一氧化氮(NO)后才会发生。因此,CysNO可被视为一种细胞靶向的NO释放剂。然而CysNO还可作为一种不依赖NO的硫醇修饰剂,并能以浓度依赖的方式损害细胞抗氧化防御。观察到的CysNO依赖性cGMP积累的双相性质似乎是由于这两种相互竞争的机制所致。在较高浓度时,CysNO可能通过直接修饰酶上的必需硫醇基团或由于更广泛的氧化应激而使鸟苷酸环化酶失活。我们在此表明,较高浓度的CysNO可将细胞S-亚硝基硫醇含量增加到非生理水平,消耗细胞内谷胱甘肽,并同时抑制cGMP形成。尽管有人提出通过S-亚硝基化抑制sGC是硝基血管扩张剂耐受性的一种机制,但就CysNO而言,这似乎更多地反映了CysNO暴露后细胞内产生的非生理水平的S-亚硝基硫醇对细胞造成的广泛氧化应激。